Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine whether the combination of MM-121 plus docetaxel is more effective than docetaxel alone in regards to PFS in patients with heregulin-positive NSCLC.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Elevation Oncology
Collaborators
NCT01717924 · Signet Ring Cell Gastric Adenocarcinoma
NCT07489716 · Non-Small Cell Lung Cancer
NCT07444437 · Non-Small Cell Lung Cancer
NCT07417488 · Colorectal Cancer, Small Bowel Adenocarcinoma
NCT07154290 · Advanced/Metastatic Non-Small Cell Lung Cancer
Tucson, Arizona
Los Angeles, California
Santa Rosa, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions